New Jersey A 5117: Prohibits substitution of prescribed epilepsy medication without notification and written consent of physician and patient; requires prescription to include notation of epilepsy diagnosis.

Status: Introduced in the Assembly, Referred to Assembly Health and Senior Services Committee (as of 2017-07-13)

State: New Jersey · Session: 217 · Bill: A 5117

Subjects: HUMAN SVCS, PHARMACEUTIC

Sponsors: Greenwald, Louis D., Vainieri Huttle, Valerie

View New Jersey A 5117 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.